Clinical Trial Update: Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer

View source ↗

Summary

This entry describes an ongoing clinical trial evaluating the risk of cardiovascular adverse events related to immune checkpoint inhibitors in cancer patients. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Thrombosis
• Atherosclerosis
• Cancer
• Cardiovascular Disease
• Coronary Artery Disease
• Myocardial Infarction
• Stroke

Snippet

Sponsor: Hanneke W. M. van Laarhoven | Conditions: Cardiovascular Diseases, Arterial Thrombosis | Status: RECRUITING